Pantheon Investment Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,604
Closed -$795K 80
2021
Q3
$795K Buy
5,604
+181
+3% +$26.6K 0.68% 51
2021
Q2
$847K Buy
5,423
+993
+22% +$161K 0.71% 49
2021
Q1
$688K Buy
4,430
+172
+4% +$26.6K 0.66% 50
2020
Q4
$637K Sell
4,258
-277
-6% -$39.1K 0.7% 51
2020
Q3
$599K Sell
4,535
-996
-18% -$130K 0.71% 48
2020
Q2
$641K Buy
+5,531
New +$637K 0.8% 44

Other funds holding ZBH

Pantheon Investment Group's ZBH Position: Q4 2021 in Review

Pantheon Investment Group sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 5,604 shares — an estimated $795K sold.

Pantheon Investment Group first reported a position in ZBH in Q2 2020 and held it in 6 quarters. The position peaked at $847K in Q2 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Pantheon Investment Group reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Pantheon Investment Group sold 5,604 Zimmer Biomet shares in Q4 2021, an estimated $795K.
  • Pantheon Investment Group first reported a position in Zimmer Biomet in Q2 2020 and held it in 6 quarters.
  • Pantheon Investment Group's Zimmer Biomet position peaked at $847K in Q2 2021.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Pantheon Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.